Corporate social responsibility

CSR and COVID-19:
the initiatives for stakeholders

As a pharmaceutical company, Alfasigma has been engaging in Corporate Social Responsibility for years and in this emergency period, where everyone is obliged to practice social distancing, we have strived to solidify and maintain our relationships with stakeholders by supporting them through numerous initiatives across the world. Healthcare professionals, doctors, hospitals, employees and local cultural organisations are the backbone in the fight against COVID-19. To support these pillars, Alfasigma decided to launch a National Health System aid programme, which has developed on a large scale worldwide through the company’s subsidiaries.

In Italy, actions supporting employees, healthcare professionals and families in trouble

For Alfasigma, the health of its employees, their families and its partners in the health system and the community, as well as maintaining business continuity, have always been a priority. From the very beginning of the emergency, the company implemented containment measures to prevent the spread of the virus and protect its workers

Most of the staff shifted to home working, drawing upon the experience gained over the last few years in which the company had already adopted remote working. 

To keep its commitment to doctors and patients, production in Alanno, Pomezia and Sermoneta plants was never interrupted as workers continued in their everyday activities. To thank its employees and collaborators for their effort, the company introduced an extraordinary and temporary gross indemnity payment of 10 euros per day of actual presence on site for the months of March and April.  

And thanks to the great work of all of its employees, the company was able to donate 180,000 euros to Caritas Italia. Through a fundraising initiative, workers at Alfasigma and Biosint donated a portion of their hourly compensation as they chose. The company supplemented the fundraising before the donation. With the funds, Caritas Italia purchased food products and distributed them to families and individuals experiencing economic hardship during the crisis.

Moreover, Alfasigma responded to the appeal of the Pomezia Chapter of the Italian Red Cross, donating four much needed refrigerators to store the food supplies destined for families in distress around Pomezia.

To help those fighting COVID-19 on the front line, Alfasigma participated in the fundraising initiative “Insieme senza Paura” (Together without Fear) promoted by the FIMMG – the Italian Federation of General Practitioners – with Active Citizenship for the sourcing and distribution of personal protective equipment for all primary care doctors. In fact, the so-called “FAB13” Italian pharmaceutical companies under the Farmindustria association – which are Abiogen Pharma, Alfasigma, Angelini, Chiesi, Dompè, I.B.N. Savio, Italfarmaco, Kedrion, Neopharmed Gentili, Menarini, Molteni, Recordati, Zambon – donated over 3 million euros in goods and funding to this cause. Though internationalised, these companies have chosen to remain based in Italy and they invest over 1 billion euros in Italy each year, employing 50,000 people in research and production.

To support the Italian Regions hosting the Alfasigma facilities with the greatest number of employees (Emilia-Romagna, Lazio and Abruzzo), the company decided to funnel targeted donations to meet the specific needs of the areas. For the Town of San Felice sul Panaro (Modena province, Emilia-Romagna), Alfasigma decided to contribute actively towards the purchase of masks and PPE for the people in the area. 

Alfasigma implementing its commitments abroad like at home 

Alfasigma’s foreign offices (China, Belgium, Tunisia, Spain, Romania, Mexico, Portugal and Poland, for now) were also active, directly supporting the work of those who were on the front-line during the emergency through money donations or by supplying personal protective equipment, biomedical equipment (e.g. ventilators) and other necessity goods. 

Read More

Mutual growth, transparency and patient centricity are the values that guide our dialogue with the medical community.
Listening to the patients and supporting those who care for them is one of our most important goals.
Social contract between the company and internal and external stakeholders having a normative value for the entire Alfasigma system.